Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.73 |
| ▸ | HTT | P42858 | 1/20 | 0.73 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.56 |
| ▸ | MEN1 | O00255 | 4/20 | 0.56 |
| ▸ | CXCR2 | P25025 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 5/20 | 0.53 |
| ▸ | NPC1 | O15118 | 3/20 | 0.53 |
| ▸ | RAB9A | P51151 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7269751 | 0.86 | HTT (0.68) | ALDH1A1HTTSMN1; SMN2KMT2AMEN1 | |
| SCHEMBL6836552 | 0.84 | KMT2A (0.61) | ALDH1A1HTTSMN1; SMN2KMT2AMEN1 | |
| SCHEMBL6838424 | 0.84 | LMNA (0.56) | ALDH1A1HTTSMN1; SMN2KMT2AMEN1 | |
| SCHEMBL29643255 | 0.84 | SMN1; SMN2 (1.00) | ALDH1A1HTTSMN1; SMN2KMT2AMEN1 | |
| SCHEMBL4228749 | 0.84 | SMN1; SMN2 (1.00) | ALDH1A1HTTSMN1; SMN2KMT2AMEN1 | |
| SCHEMBL6836390 | 0.84 | NPC1 (0.62) | ALDH1A1HTTSMN1; SMN2KMT2AMEN1 | |
| SCHEMBL7764411 | 0.83 | KMT2A (0.54) | ALDH1A1HTTSMN1; SMN2KMT2AMEN1 | |
| SCHEMBL7264600 | 0.83 | ALDH1A1 (0.73) | ALDH1A1HTTSMN1; SMN2KMT2AMEN1 | |
| SCHEMBL2748272 | 0.82 | ALDH1A1 (0.53) | ALDH1A1HTTSMN1; SMN2KMT2AMEN1 | |
| SCHEMBL28515684 | 0.81 | KMT2A (0.57) | ALDH1A1HTTSMN1; SMN2KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6752839-B1 | 2-SUBSTITUTED 5-AMINOALKYLPHENOL DERIVATIVE COUPLER AND PYRAZOLES, CERTAIN PYRIMIDINES AND/OR PYRAZOLOPYRIMIDINES BASES; CHROMATIC, STRONG, AESTHETIC COLORATIONS IN VARIETY OF SHADES | L'OREAL (FR) | 2004-06-22 | — | — | US | claimed |
| US-6530960-B1 | Oxidative base at least one 2-substituted 5-aminoalkylphenol coupler; chromatic, strong, aesthetic colorations in a variety of shades | L'OREAL S.A. (FR) | 2003-03-11 | — | — | US | claimed |
| EP-1093788-A1 | Oxydative dyeing composition for keratinic fibres and dyeing process using this composition | L'OREAL (FR) | 2001-04-25 | — | — | EP | claimed |
| EP-1093790-A2 | Oxydative dyeing composition for keratinic fibres and dyeing process using this composition | L'OREAL (FR) | 2001-04-25 | — | — | EP | claimed |
| EP-1093789-A1 | Composition for oxidative dyeing of keratinous fibres and dyeing process using the same | L'OREAL (FR) | 2001-04-25 | — | — | EP | claimed |
| EP-1093791-A1 | Composition for oxidative dyeing of keratinous fibres and dyeing process using same | L'OREAL (FR) | 2001-04-25 | — | — | EP | claimed |
| EP-1093793-A2 | Composition for oxidative dyeing of keratinous fibres and dyeing process using same | L'OREAL (FR) | 2001-04-25 | — | — | EP | claimed |
| EP-1093792-A1 | Composition for oxidative dyeing of keratinous fibres and dyeing process using the same | L'OREAL (FR) | 2001-04-25 | — | — | EP | claimed |
| US-11230680-B2 | Methods for preparing fuel additives | BP OIL INTERNATIONAL LIMITED (GB) | 2022-01-25 | — | — | US | disclosed |
| US-11230680-B2 | Methods for preparing fuel additives | BP OIL INTERNATIONAL LIMITED (GB) | 2022-01-25 | — | — | US | disclosed |
| CN-111936474-A | Method for preparing fuel additive | 英国石油国际有限公司 | 2020-11-13 | — | — | CN | disclosed |
| EP-3732171-A1 | METHODS FOR PREPARING FUEL ADDITIVES | BP Oil International Limited (GB) | 2020-11-04 | — | — | EP | disclosed |
| US-20200332208-A1 | Methods for Preparing Fuel Additives | BP OIL INTERNATIONAL LIMITED (GB) | 2020-10-22 | — | — | US | disclosed |
| US-20200332208-A1 | Methods for Preparing Fuel Additives | BP OIL INTERNATIONAL LIMITED (GB) | 2020-10-22 | — | — | US | disclosed |
| EP-1093788-A1 | Oxydative dyeing composition for keratinic fibres and dyeing process using this composition | L'OREAL (FR) | 2001-04-25 | — | — | EP | disclosed |
| EP-1093790-A2 | Oxydative dyeing composition for keratinic fibres and dyeing process using this composition | L'OREAL (FR) | 2001-04-25 | — | — | EP | disclosed |
| EP-1066263-A1 | NOVEL CATIONIC 2-ACYLAMINOPHENOLS, THEIR USE AS COUPLER FOR OXIDATION DYEING, COMPOSITIONS CONTAINING THEM, AND DYEING METHODS | L'OREAL (FR) | 2001-01-10 | — | — | EP | disclosed |
| WO-2000043368-A1 | NOVEL CATIONIC 2-ACYLAMINOPHENOLS, THEIR USE AS COUPLER FOR OXIDATION DYEING, COMPOSITIONS CONTAINING THEM, AND DYEING METHODS | L'OREAL (FR) | 2000-07-27 | — | — | WO | disclosed |
| US-5334225-A | Imparts color tone of high chroma; excellent in coloring power and fastness | KAO CORPORATION (JP) | 1994-08-02 | — | — | US | disclosed |
| EP-0579204-A2 | Dye composition for a keratinous fiber | KAO CORPORATION (JP) | 1994-01-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11230680-B2 | Methods for preparing fuel additives | ADH1A, ADH1C, HOGA1 | ALDH1A1 130/4885HTT 2089/4885SMN1; SMN2 1523/4885 |
| US-20200332208-A1 | Methods for Preparing Fuel Additives | ADH1A, ADH1C, HOGA1 | ALDH1A1 130/4885HTT 2089/4885SMN1; SMN2 1523/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.